Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Mitsubishi Tanabe Pharma discovers MC1 receptor agonists

June 16, 2017

ACEA completes phase I trial of AC-0058

June 15, 2017

FDA grants rare pediatric disease designation to Fibrocell Science's FCX-013

June 13, 2017

Medivir gives update on phase IIa extension study of MIV-711

June 12, 2017

Upadacitinib meets all primary and secondary endpoints in phase III SELECT-NEXT study

June 9, 2017

Subcutaneous Orencia available for patients 2 years of age and older

June 9, 2017

Bristol-Myers Squibb patents TYK2 inhibitors

June 8, 2017

BAMBI inhibition is beneficial in autoimmune diseases

May 31, 2017

FDA approves Kevzara for rheumatoid arthritis

May 23, 2017

Emmyon patents new furostan-3-ol derivatives

May 23, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...